Christopher Von Seggern is Chief Commercial Officer of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 4,000 shares of XENE, which is worth approximately $164,440. The most recent transaction as insider was on Dec 06, 2021, when has been sold 4,000 shares (Common Shares) at a price of $24.4 per share, resulting in proceeds of $97,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K
0% 3M change
0% 12M change
Total Value Held $164,440

Christopher Von Seggern Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2021
BUY
Open market or private purchase
$97,600 $24.4 p/Share
4,000 Added 50.0%
4,000 Common Shares
CVS

Christopher Von Seggern

Chief Commercial Officer
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE